Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease

Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease

Objective The development of sufficient COVID-19 vaccines has been a big breakthrough in fighting the global SARS-CoV-2 pandemic. However, vaccination effectiveness can be reduced in patients with autoimmune rheumatic diseases (AIRD). The aim of this study was to identify factors that lead to a dimi...

Full description

Bibliographic Details
Main Authors: Tatjana Schwarz, Gerd-Rüdiger Burmester, Florian Kurth, Jan Zernicke, Jens Klotsche, Tanja Braun, Amanthi Nadira Arumahandi de Silva, Leonie Maria Frommert, Veronika Scholz, Lara Maria Jeworowski, Victor Max Corman, Pinkus Tober-Lau, Leif Erik Sander
Format: Article
Language:English
Published: BMJ Publishing Group 2022-11-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/8/2/e002650.full

Internet

https://rmdopen.bmj.com/content/8/2/e002650.full

Similar Items